Treatment of pre-pubertal patients with growth hormone deficiency: Patterns in growth hormone dosage and insulin-like growth factor-I Z-scores

Megan Oberle, Adda Grimberg, Vaneeta Bamba

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

Objective: To describe the range of insulin-like growth factor-I (IGF-I) z-score values (IGF-Iz) and growth hormone (GH) dose adjustments in pre-pubertal patients with GH deficiency (GHD) treated with GH in a single tertiary care center. Methods: This is a retrospective review of GH-treated patients of ages ≤9 years with GHD, seen in an endocrinology clinic in 2013-2014. Patient demographics and pre-treatment anthropometrics, GH treatment duration, IGF-Iz, and GH dosage (mg/kg/week) were extracted. Multipredictor linear regression was used to evaluate the associations between IGF-Iz and GH dosage and subject gender, race, insurance type, age, and clinical characteristics. Logistic regression was used to calculate the odds ratio of direction of GH dose adjustment (decrease/no change versus increase) and IGF-Iz category based on patient clinical characteristics, accounting for provider random effect. Results: Forty-one percent (57/139) of IGF-Iz were outside the “normal” range of between -2 and +2 standard deviation; the majority of IGF-Iz beyond the “normal” range (93%) were supraphysiologic [>+2 standard deviation score (SDS)]. Of the IGF-Iz >+2, 10/53 (18%) were followed by a GH dose increase and 30/53 (57%) had no dose change. Patient clinical characteristics and demographics did not significantly increase the odds of being in the IGF-Iz >+2 SDS category or having a dose increase in multipredictor logistic regression models. Conclusion: GH dosages and IGF-Iz varied, without significant patient clinical predictors. IGF-Iz was frequently supraphysiologic, and these levels often did not prompt a reduction in GH dose, likely influenced by a variety of factors. Our study emphasizes the need for better understanding of long-term safety and efficacy of maintaining supraphysiologic levels of IGF-Iz.

Original languageEnglish (US)
Pages (from-to)208-215
Number of pages8
JournalJCRPE Journal of Clinical Research in Pediatric Endocrinology
Volume9
Issue number3
DOIs
StatePublished - Sep 2017

Keywords

  • Clinical decision making
  • Growth
  • Growth hormone deficiency
  • Growth hormone therapy
  • Insulin-like growth factor-I

Fingerprint Dive into the research topics of 'Treatment of pre-pubertal patients with growth hormone deficiency: Patterns in growth hormone dosage and insulin-like growth factor-I Z-scores'. Together they form a unique fingerprint.

  • Cite this